Since PI3K-AKT-mTOR axis and NRLC3 regulation have attracted more and more attention in cancer research, we have preliminarily found that GSC could inhibit mTOR activation in A549 cells and another manuscript is in preparation (Karki et al., 2017a,b). Here, AKT1 is linked to cancer.